Exosome Diagnostics Places Early Access Shahky™ Exosomal Protein Detection System at MGH Center for Systems Biology
January 09, 2018 07:46 ET | Exosome Diagnostics
Waltham, MA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has placed an Early Access version of its commercial Shahky system, which quantitively measures exosomal proteins, at...
MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna
December 22, 2017 18:02 ET | MolecularMD
PORTLAND, Ore. and CAMBRIDGE, Mass., Dec. 22, 2017 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a  diagnostics company that enables the development and commercialization of precision medicines in...
Exosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung Cancer
December 19, 2017 07:51 ET | Exosome Diagnostics
Waltham, MA, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., recently published a study in the Journal Annals of Oncology, of EGFR Liquid Biopsy detection in patients with Non-Small...
gmi logo.jpg
Precision Medicine Market growing at 10.5% CAGR to hit $96 bn by 2024
October 26, 2017 07:00 ET | Global Market Insights, Inc
Ocean View, Delaware, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Precision Medicine Market is expected to cross USD 96 billion by 2024; according to a new research report by Global Market Insights. Rising...
Logo-BCC-Research.jpg
Speaker Series Event: Companion Diagnostics & Personalized Medicine on Nov. 9
October 23, 2017 07:45 ET | BCC Research
WELLESLEY, Mass., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Analyst Marianna Tcherpakov and Senior Editor Robert G. Hunter will lead a presentation on companion diagnostics and personalized medicine. BCC...
Logo-BCC-Research.jpg
Liquid Biopsy Tools, Diagnostics Market to Reach $4.5B by 2022
October 10, 2017 15:45 ET | BCC Research
WELLESLEY, Mass., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Liquid biopsy is rapidly gaining traction as a supplement or alternative to tissue biopsy, with the potential to attain a global market value of...
Logo-BCC-Research.jpg
CDx Market Forecast Update: Congress Approves NIH Funding
August 07, 2017 05:00 ET | BCC Research
Wellesley, Mass., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Recently in March 2017, the FDA identified more than 1,000 Class II devices that it plans to exempt from 510(k) premarket notification...
Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention
June 22, 2017 11:54 ET | Exosome Diagnostics
Boston, MA, June 22, 2017 (GLOBE NEWSWIRE) -- John Boyce, President and CEO of Exosome Diagnostics Inc., a leader in the liquid biopsy space, presented a talk entitled “The True Liquid Biopsy”...
Logo-BCC-Research.jpg
Companion Diagnostic Market to Reach US$6.09 Billion by 2021
March 15, 2017 07:30 ET | BCC Research
Wellesley, Mass, March 15, 2017 (GLOBE NEWSWIRE) -- BCC Research has published an important analysis of the development of— and prospects for— the companion diagnostic (CDx) market. Key to...
Provista Diagnostics, Inc. expands its contract research offerings through its Provista Dx Reference Laboratory
January 09, 2013 12:58 ET | Provista Diagnostics, Inc.
Scottsdale, Arizona, Jan. 9, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a leading molecular diagnostics company, is pleased to announce the addition of new contract research services and...